LC
IDXX icon

Lindbrook Capital’s Idexx Laboratories IDXX Stock Holding History

Lindbrook Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$236K Buy
562
+274
+95% +$119K 0.02% 364
2024
Q4 		$119K Sell
288
-53
-16% -$23.2K 0.01% 510
2024
Q3 		$172K Buy
341
+15
+5% +$7.29K 0.02% 425
2024
Q2 		$159K Buy
326
+18
+6% +$9.04K 0.01% 410
2024
Q1 		$166K Buy
308
+5
+2% +$2.73K 0.02% 397
2023
Q4 		$168K Buy
303
+55
+22% +$25.8K 0.02% 380
2023
Q3 		$108K Sell
248
-45
-15% -$22.4K 0.01% 444
2023
Q2 		$147K Buy
293
+51
+21% +$24.4K 0.02% 395
2023
Q1 		$121K Buy
242
+107
+79% +$51.2K 0.01% 433
2022
Q4 		$55.1K Buy
135
+78
+137% +$30.3K 0.01% 663
2022
Q3 		$19K Buy
57
+12
+27% +$4.41K ﹤0.01% 1007
2022
Q2 		$16K Buy
45
+6
+15% +$2.45K ﹤0.01% 1061
2022
Q1 		$21K Sell
39
-18
-32% -$9.47K ﹤0.01% 985
2021
Q4 		$38K Buy
57
+11
+24% +$6.91K 0.01% 810
2021
Q3 		$29K Buy
46
+4
+10% +$2.69K 0.01% 612
2021
Q2 		$27K Sell
42
-10
-19% -$5.52K 0.01% 670
2021
Q1 		$25K Buy
52
+22
+73% +$11K 0.01% 671
2020
Q4 		$15K Buy
30
+12
+67% +$5.37K ﹤0.01% 772
2020
Q3 		$7K Sell
18
-81
-82% -$29.9K ﹤0.01% 962
2020
Q2 		$33K Sell
99
-7
-7% -$2.03K 0.01% 464
2020
Q1 		$26K Buy
106
+16
+18% +$4.18K 0.01% 468
2019
Q4 		$24K Buy
90
+11
+14% +$2.9K 0.01% 671
2019
Q3 		$21K Sell
79
-8
-9% -$2.23K 0.01% 694
2019
Q2 		$23K Buy
87
+8
+10% +$1.97K 0.01% 646
2019
Q1 		$17K Buy
79
+75
+1,875% +$15.5K 0.01% 752
2018
Q4 		$0 Buy
+4
New +$820 ﹤0.01% 1393

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Lindbrook Capital's IDXX Position: Q1 2025 in Review

Lindbrook Capital increased its Idexx Laboratories (IDXX) stake by 95% in Q1 2025, buying an estimated $119K and bringing the position to 562 shares worth $236K. The position accounts for 0.02% of the portfolio, ranked #364.

Lindbrook Capital first reported a position in IDXX in Q4 2018 and has held it in 26 quarters since. 1,143 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Lindbrook Capital held 562 shares of Idexx Laboratories worth $236K as of Q1 2025.
  • Lindbrook Capital bought 274 Idexx Laboratories shares in Q1 2025, an estimated $119K.
  • Idexx Laboratories made up 0.02% of Lindbrook Capital's portfolio in Q1 2025, its #364 holding.
  • Lindbrook Capital first reported a position in Idexx Laboratories in Q4 2018 and has held it in 26 quarters since.
  • 1,143 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.